Nanoparticle Size Is a Critical Physico-chemicalDeterminantoftheHumanBlood PlasmaCorona : AComprehensive Quantitative ProteomicAnalysis

Stefan Tenzer, Dominic Docter, Susanne Rosfa, AlexandraWlodarski, Jörg Kuharev, Alexander Rekik, Shirley K. Knauer,ChristophBantz, ) ThomasNawroth, Carolin Bier, Jarinratn Sirirattanapan,WolfMann, Lennart Treuel, Reinhard Zellner, Michael Maskos, )," Hansjörg Schild, and Roland H. Stauber* Institute for Immunology, University Medical Center of the Johannes-Gutenberg University Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany, Molecular and Cellular Oncology/Mainz Screening Center (MSC), University Medical Center of the Johannes-Gutenberg University Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany, Institute for Molecular Biology, Centre for Medical Biotechnology (ZMB), University Duisburg Essen, Universitätsstrasse, 45117 Essen, Germany, Institute of Physical Chemistry, University Mainz, Jakob Welder Weg 11, 55099 Mainz, Germany, Department of Biopharmaceutics and Pharmaceutical Technology, Institute for Pharmacy, University Mainz, Staudingerweg 5, 55099 Mainz, Germany, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany, Faculty of Medicine, Srinakharinwirot University, Sukhumwit 23, Wattana, Bangkok 10110, Thailand, Institute for Physical Chemistry and Center for Nanointegration Duisburg Essen (CeNIDE), University of Duisburg Essen, Universitaetsstrasse 5-7, 45117 Essen, Germany, and BAM, Bundesanstalt für Materialforschung und -prüfung, Division 6.3 Durability of Polymers, Unter den Eichen 87, 12205 Berlin, Germany. These authors contributed equally.

[1]  R. Müller,et al.  Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  Rainer H Müller,et al.  Functional groups on polystyrene model nanoparticles: influence on protein adsorption. , 2003, Journal of biomedical materials research. Part A.

[3]  M. Morandi,et al.  Nanoparticle‐induced platelet aggregation and vascular thrombosis , 2005, British journal of pharmacology.

[4]  M. Gorenstein,et al.  Absolute Quantification of Proteins by LCMSE , 2006, Molecular & Cellular Proteomics.

[5]  Christoph Alexiou,et al.  Targeting cancer cells: magnetic nanoparticles as drug carriers , 2006, European Biophysics Journal.

[6]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[7]  Benjamin Gilbert,et al.  Extracellular Proteins Limit the Dispersal of Biogenic Nanoparticles , 2007, Science.

[8]  Sara Linse,et al.  Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.

[9]  Sara Linse,et al.  The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. , 2007, Advances in colloid and interface science.

[10]  W. Witke,et al.  Gelsolin and diseases. , 2007, Sub-cellular biochemistry.

[11]  M. Reilly,et al.  HDL proteomics: pot of gold or Pandora's box? , 2007, The Journal of clinical investigation.

[12]  M. Dobrovolskaia,et al.  Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.

[13]  J. Klein.  Probing the interactions of proteins and nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[14]  Subramaniam Pennathur,et al.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. , 2007, The Journal of clinical investigation.

[15]  Anil K Patri,et al.  Method for analysis of nanoparticle hemolytic properties in vitro. , 2008, Nano letters.

[16]  Mauro Ferrari,et al.  Nanogeometry: beyond drug delivery. , 2008, Nature nanotechnology.

[17]  N Leigh Anderson,et al.  High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. , 2008, Clinical chemistry.

[18]  May D. Wang,et al.  In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags , 2008, Nature Biotechnology.

[19]  Mark J DiNubile.  Plasma gelsolin as a biomarker of inflammation , 2008, Arthritis research & therapy.

[20]  Parag Aggarwal,et al.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.

[21]  Yuval Golan,et al.  The role of interparticle and external forces in nanoparticle assembly. , 2008, Nature materials.

[22]  P. Janmey,et al.  Plasma gelsolin: function, prognostic value, and potential therapeutic use. , 2008, Current protein & peptide science.

[23]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[24]  Marina A Dobrovolskaia,et al.  Evaluation of nanoparticle immunotoxicity. , 2009, Nature nanotechnology.

[25]  James S Murday,et al.  Translational nanomedicine: status assessment and opportunities. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[26]  Stefan Tenzer,et al.  Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. , 2009, Nature immunology.

[27]  Mauro Ferrari,et al.  Nanomedicine--challenge and perspectives. , 2009, Angewandte Chemie.

[28]  U. Goldbourt,et al.  Apolipoproteins and long-term prognosis in coronary heart disease patients. , 2009, American Heart Journal.

[29]  Sara Linse,et al.  Complete high‐density lipoproteins in nanoparticle corona , 2009, The FEBS journal.

[30]  S. Hanash,et al.  BiomarkerDigger: A versatile disease proteome database and analysis platform for the identification of plasma cancer biomarkers , 2009, Proteomics.

[31]  Scott E McNeil,et al.  Nanoparticle therapeutics: a personal perspective. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[32]  Iseult Lynch,et al.  Protein-nanoparticle interactions: What does the cell see? , 2009, Nature nanotechnology.

[33]  T. Xia,et al.  Potential health impact of nanoparticles. , 2009, Annual review of public health.

[34]  Darren J. Martin,et al.  Differential plasma protein binding to metal oxide nanoparticles , 2009, Nanotechnology.

[35]  Wolfgang J Parak,et al.  A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. , 2009, Nature nanotechnology.

[36]  Feng Zhang,et al.  Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding , 2010, Journal of The Royal Society Interface.

[37]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[38]  Parag Aggarwal,et al.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.

[39]  Parag Aggarwal,et al.  Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[40]  Francesco Stellacci,et al.  Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.

[41]  Reinhard Zellner,et al.  The influence of surface composition of nanoparticles on their interactions with serum albumin. , 2010, Chemphyschem : a European journal of chemical physics and physical chemistry.

[42]  Iseult Lynch,et al.  What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.

[43]  R. Marschalek,et al.  Cell-based Analysis of Structure-Function Activity of Threonine Aspartase 1* , 2010, The Journal of Biological Chemistry.

[44]  W. Mann,et al.  An otoprotective role for the apoptosis inhibitor protein survivin , 2010, Cell Death and Disease.

[45]  Susan M Resnick,et al.  Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. , 2010, Archives of general psychiatry.

[46]  Sara Linse,et al.  Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid , 2010, PloS one.

[47]  Jerzy Leszczynski,et al.  Bionanoscience: Nano meets bio at the interface. , 2010, Nature nanotechnology.

[48]  Scott E McNeil,et al.  Nanomaterial standards for efficacy and toxicity assessment. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[49]  Christine Pohl,et al.  Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: Comparison with conventional monocultures , 2011, Particle and Fibre Toxicology.

[50]  M. Maskos,et al.  Characterization of polymer nanoparticles by asymmetrical flow field flow fractionation (AF-FFF). , 2010, Journal of nanoscience and nanotechnology.

[51]  Jack F Douglas,et al.  Interaction of gold nanoparticles with common human blood proteins. , 2010, ACS nano.

[52]  D. Begley,et al.  Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain , 2010, Journal of drug targeting.

[53]  Albert Duschl,et al.  Time evolution of the nanoparticle protein corona. , 2010, ACS nano.

[54]  M. Mahmoudi,et al.  Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.

[55]  Iseult Lynch,et al.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.

[56]  B. Adryan,et al.  Analysis of differentially expressed proteins in oral squamous cell carcinoma by MALDI-TOF MS. , 2011, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[57]  Gilbert S Omenn,et al.  Data management and data integration in the HUPO plasma proteome project. , 2011, Methods in molecular biology.

[58]  R. Aebersold,et al.  A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas* , 2011, Molecular & Cellular Proteomics.